课题基金 / 基金详情

TREATMENT OF OSTEOPOROSIS WITH DICLOFENAC SODIUM

TREATMENT OF OSTEOPOROSIS WITH DICLOFENAC SODIUM
双氯芬酸钠治疗骨质疏松症
批准号：
3851793
负责人：
NORMAN H. BELL
金额：
$0.0万
依托单位：
MEDICAL UNIVERSITY OF SOUTH CAROLINA
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3851793
关键词：
antiinflammatory agents bone metabolism chemoprevention female human subject human therapy evaluation osteoporosis pathologic bone resorption postmenopause prostaglandin inhibitors skeletal disorder chemotherapy

项目摘要

项目成果

NORMAN H. BELL的其他基金

相似基金

相关文献

中文摘要
翻译
对实验动物的研究表明，前列腺素调节正在进行 骨吸收和雌激素抑制前列腺素的合成。一个 调查开始检验双氯芬酸钠，一种 非类固醇抗炎药，将有助于预防 绝经后骨质流失。绝经前妇女的研究结果表明， 药物导致尿钙减少20%，绝经后妇女 尿钙减少了40%。
英文摘要
Studies in laboratory animals suggest that prostaglandins mediate ongoing bone resorption and that estrogen inhibits prostaglandin synthesis. An investigation was begun to test the hypothesis that diclofenac sodium, a nonsteroidal anti-inflammatory drug, would be useful in preventing postmenopausal bone loss. Results in premenopausal women indicate that the drug produced a 20% decrease in urinary calcium and in postmenopausal women a 40% decrease in urinary calcium.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
1-25 DIHYDROXYVITAMIN D3 AND HYPERCALCEMIA
PARATHYROID HORMONE AND AGING
TREATMENT OF OSTEOPOROSIS WITH DICLOFENAC SODIUM
TREATMENT OF OSTEOPOROSIS WITH DICLOFENAC SODIUM
海外基金